Research Article

Exploring the Mechanism of Action Compound-Xueshuantong Capsule in Diabetic Retinopathy Treatment Based on Network Pharmacology

Table 3

Target enrichment pathway of Compound-Xueshuantong Capsule in diabetic retinopathy treatment.

IDDescriptionGene IDCount

hsa04933AGE-RAGE signaling pathway in diabetic complicationsRELA/VEGFA/CCND1/IL6/CASP3/ICAM1/BCL2/MAPK8/SELE/VCAM1/PRKCA/NOS312
hsa05418Fluid shear stress and atherosclerosisRELA/VEGFA/ICAM1/GSTP1/BCL2/FOS/MAPK8/SELE/VCAM1/GSTM1/CAV1/NOS3/NFE2L213
hsa04210ApoptosisRELA/CASP9/CASP3/CASP7/MCL1/BIRC5/BCL2/FOS/MAPK8/RAF1/PARP1/CTSD12
hsa04668TNF signaling pathwayRELA/IL6/CASP3/CASP7/ICAM1/FOS/MAPK8/SELE/VCAM1/IRF110
hsa05210Colorectal cancerEGFR/CCND1/CASP9/CASP3/BIRC5/BCL2/FOS/MAPK8/RAF19
hsa05161Hepatitis BRELA/CASP9/IL6/CASP3/PCNA/BIRC5/BCL2/FOS/MAPK8/RAF1/PRKCA11
hsa05215Prostate cancerAR/RELA/EGFR/CCND1/CASP9/GSTP1/BCL2/PLAU/RAF19
hsa05167Kaposi sarcoma-associated herpesvirus infectionRELA/VEGFA/CCND1/CASP9/IL6/CASP3/ICAM1/FOS/MAPK8/RAF1/HIF1A11
hsa05133PertussisRELA/IL6/CASP3/CASP7/FOS/MAPK8/IRF1/CASP18
hsa04215Apoptosis-multiple speciesCASP9/CASP3/CASP7/BIRC5/BCL2/MAPK86
hsa05205Proteoglycans in cancerESR1/EGFR/VEGFA/CCND1/CASP3/PLAU/RAF1/PRKCA/HIF1A/CAV1/IGF211
hsa04917Prolactin signaling pathwayESR1/RELA/CCND1/FOS/MAPK8/RAF1/IRF17
hsa04066HIF-1 signaling pathwayRELA/EGFR/VEGFA/IL6/BCL2/PRKCA/HIF1A/NOS38
hsa05212Pancreatic cancerRELA/EGFR/VEGFA/CCND1/CASP9/MAPK8/RAF17
hsa05163Human cytomegalovirus infectionRELA/EGFR/VEGFA/CCND1/CASP9/IL6/CASP3/RAF1/PRKCA/PTGER310
hsa04926Relaxin signaling pathwayRELA/CASP9/IL6/CASP3/CASP7/CASP16
hsa05134LegionellosisRELA/CASP9/IL6/CASP3/NFKBIA/CASP7/CASP8/HSF1/CASP19
hsa04370VEGF signaling pathwayVEGFA/CASP9/RAF1/PRKCA/NOS3/HSPB16
hsa04151PI3K-Akt signaling pathwayRELA/EGFR/VEGFA/CCND1/CASP9/IL6/MCL1/BCL2/RAF1/PRKCA/NOS3/IGF212
hsa04915Estrogen signaling pathwayPGR/ESR1/EGFR/BCL2/FOS/RAF1/NOS3/CTSD8